HPN-01 (IKK inhibitor XII) is a selective inhibitor of IKK-alpha, IKK-beta, and IKK-epsilon. It has demonstrated efficacy in an experimental autoimmune encephalomyelitis (EAE) mouse model, reducing disease severity, modulating immune responses, and extending lifespan, making it a valuable tool for studying autoimmune and inflammatory disorders.